Taken together, our findings identified ECHS1 mutations as a cause of a new clinical entity characterized by an early onset, very severe (Leigh-like) mitochondrial encephalopathy with deafness, epilepsy, optic atrophy, and cardiomyopathy. The gene discussed is ECHS1; the disease is deafness.